Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Czech Republic - University Hospital
Prague, Czechia
Recruiting
- Medizinische Hochschule Hannover
Hanover, Germany
Recruiting - Helios Park-Klinikum Leipzig
Leipzig, Germany
Recruiting
- Instiuto Europeo de Oncologia
Milan, Italy
Recruiting
- Leiden University Medical Center (lumc)
Leiden, Netherlands
Recruiting
- Clinical Hospital Center "bezanijska Kosa"
Belgrade, Serbia
Recruiting
- Hospital Clinic Barcelona
Barcelona, Spain
Recruiting
- Izmir Ekonomi
Izmir, Turkey (Türkiye)
Recruiting
- City of Hope
Duarte, California, United States
Recruiting - Ucla Hematology/oncology-Santa Monica
Santa Monica, California, United States
Recruiting - Moffitt Cancer Center
Tampa, Florida, United States
Recruiting - the University of Kansas Clinical Research Center
Fairway, Kansas, United States
Recruiting - Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Recruiting - Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Aug 2025
- Primary completion
- 31 Dec 2026
- Completion
- 31 Oct 2027
- Last update posted
- 1 Jun 2026
- Registered enrollment
- 90
- Registry id
- NCT06607458
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.